Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors ...

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, ...

Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers ...

Cat anal glands probably aren’t leading anyone’s list of favorite health topics to talk about. But that doesn’t mean you can ...

diarrhea, weight loss and rectal bleeding. The new trial was funded by Prometheus Biosciences, which is developing ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...